Abstract
Four randomized studies show that adjuvant radiotherapy (RT) lowers the risk of subsequent ipsilateral breast events (IBEs) after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS) by approximately 50% after 10 to 15 years. We present 20 years of follow-up data for the SweDCIS trial.
Original language | English |
---|---|
Pages (from-to) | 3613 |
Journal | Journal of Clinical Oncology |
Volume | 32 |
Issue number | 32 |
DOIs | |
Publication status | Published - 2014 |
Bibliographical note
The information about affiliations in this record was updated in December 2015.The record was previously connected to the following departments: Surgery Research Unit (013242220), Paediatrics (Lund) (013002000), Pathology, (Lund) (013030000), Cancer Epidemiology (013007100)
Subject classification (UKÄ)
- Cancer and Oncology